Chhattisgarh Clinical Trials Reimbursement — Up to ₹5 Crore Subsidy

Chhattisgarh Clinical Trials Reimbursement is a state subsidy that pays back a share of what pharmaceutical companies spend on clinical trials carried out inside Chhattisgarh. The Department of Industries, Government of Chhattisgarh administers it as one of the incentives under the Chhattisgarh Industrial Development Policy 2024-30.

Clinical research is costly, and the policy treats that cost as a reason to support companies rather than a reason for them to look elsewhere. By returning part of verified trial spending, the state aims to keep drug, therapy and medical device research happening within its boundaries, draw more pharmaceutical manufacturing capacity into Chhattisgarh, and build high-skill employment along the way.

The support arrives as a reimbursement against expenses already incurred, not as an upfront grant. It is also non-dilutive — the government takes no equity in the company in return. Applications run on a rolling basis, so there is no fixed window a founder has to wait for.

• Up to 50% of clinical trial expenses reimbursed
• ₹1 crore maximum per clinical trial
• Up to 5 trials per unit, so ₹5 crore in total
• Exclusively for pharmaceutical sector industries
• Trials must be conducted within Chhattisgarh
• Rolling applications under the Chhattisgarh Industrial Development Policy 2024-30

Eligibility here is sector-specific. To claim this reimbursement, an applicant must be an industry in the pharmaceutical sector and must be conducting clinical trials in Chhattisgarh.

• Sector: pharmaceutical industries only. Units from other sectors cannot claim under this head, however large their research spend may be.
• Where the activity happens: the clinical trials themselves have to be conducted in Chhattisgarh.
• Nature of activity: clinical trials — the scheme is aimed at companies doing clinical research and development work of the kind defined in the policy.

The published criteria do not lay down a separate DPIIT recognition or MSME registration requirement, and no founder-level conditions are specified. If your unit and its trials meet the criteria set out in the Chhattisgarh Industrial Development Policy 2024-30, you are in scope.

Chhattisgarh Clinical Trials Reimbursement — Up to ₹5 Crore Subsidy is open to startups at any stage. It is open to startups registered anywhere in India.

Chhattisgarh Clinical Trials Reimbursement — Up to ₹5 Crore Subsidy accepts applications on a rolling basis — there is no fixed cut-off date, so eligible startups can apply at any time. Because rolling programmes can pause without notice, confirm the window is still open on the official site before you start.

The benefit is paid as a reimbursement against money already spent on eligible clinical trials.

• Up to 50% of the expenses incurred on clinical trials is reimbursed.
• The ceiling is ₹1 crore per clinical trial.
• A single unit can claim across a maximum of 5 clinical trials.
• Taken together, that puts the maximum benefit at up to ₹5 crore per unit.

Because this is a reimbursement, the money follows verified expenditure rather than arriving before the work starts. And because it is a subsidy rather than an investment, no equity or ownership is surrendered in exchange — the entire benefit stays with the company.

Chhattisgarh Clinical Trials Reimbursement — Up to ₹5 Crore Subsidy is offered by Department of Industries, Government of Chhattisgarh, a government body. As a government-backed subsidy, it is publicly funded and open to eligible startups across India.

Every claim is reviewed before any money is released.

• Departmental committee review. A committee drawn from the relevant government department — typically the Department of Industries — examines the application to confirm that the applicant is eligible and that the claim fits the Chhattisgarh Industrial Development Policy 2024-30.
• Expense authentication. The clinical trial expenses submitted, together with the supporting proofs, are checked to establish that the amounts claimed are genuine and allowable.
• Compliance check. The application is tested against the conditions laid down in the policy.
• Ground verification. The review may extend to site visits or audits, so that the details of the trials actually conducted can be confirmed.
• Disbursal. Once the claim clears review, the approved reimbursement is released to the unit.

Before you apply to Chhattisgarh Clinical Trials Reimbursement — Up to ₹5 Crore Subsidy, keep the following documents ready:

• A pitch deck or short business plan describing the problem, product and traction
• Company registration documents and PAN
• Founder identification (PAN / Aadhaar) and brief profiles
• Recent financial statements or projections
• Product details — a demo, prototype or working link if available

Exact requirements are confirmed on the official application portal — treat this as a preparation checklist.